Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rhea-AI Summary

Rigel Pharmaceuticals grants stock options to employees

Positive

• Rigel Pharmaceuticals granted 285,800 stock options to seven non-executive employees.
• The stock options will vest over four years with a one-year cliff.

Negative

• None.

SOUTH SAN FRANCISCO, Calif., Oct. 6, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to Rigel's Inducement Plan, approved by the Compensation Committee of Rigel's Board of Directors and granted as an inducement material to employees' entering into employment with Rigel, in accordance with NASDAQ Listing Rule 5635(c)(4). Specifically, Rigel granted 285,800 stock options to seven non-executive employees vesting over four years with a one-year cliff.

Rigel is providing this information in accordance with NASDAQ Listing Rule 5635(c)(4).

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.

Investors & Media Contacts:

Investors:
Rigel Pharmaceuticals, Inc. 
650.624.1232
ir@rigel.com

Media:
David Rosen
Argot Partners
Phone: 212.600.1902
Email: david.rosen@argotpartners.com

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-301949850.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

What did Rigel Pharmaceuticals announce?

Rigel Pharmaceuticals announced that it has granted stock options to employees.

How many stock options were granted?

Rigel Pharmaceuticals granted 285,800 stock options.

Who are the stock options granted to?

The stock options were granted to seven non-executive employees.

How long will it take for the stock options to vest?

The stock options will vest over four years with a one-year cliff.

Why did Rigel Pharmaceuticals grant these stock options?

The stock options were granted as an inducement material to employees' entering into employment with Rigel.

What rule governs the granting of these stock options?

The granting of these stock options is in accordance with NASDAQ Listing Rule 5635(c)(4).